These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22459449)

  • 1. Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx.
    Zhang C; Dai H; de Crombrugghe B
    Biochem Biophys Res Commun; 2012 Apr; 420(4):782-6. PubMed ID: 22459449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerostin is a direct target of osteoblast-specific transcription factor osterix.
    Yang F; Tang W; So S; de Crombrugghe B; Zhang C
    Biochem Biophys Res Commun; 2010 Oct; 400(4):684-8. PubMed ID: 20816666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation.
    Tang W; Li Y; Osimiri L; Zhang C
    J Biol Chem; 2011 Sep; 286(38):32995-3002. PubMed ID: 21828043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 13 (MMP13) is a direct target of osteoblast-specific transcription factor osterix (Osx) in osteoblasts.
    Zhang C; Tang W; Li Y
    PLoS One; 2012; 7(11):e50525. PubMed ID: 23185634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of bone sialoprotein gene expression by Osx.
    Yang Y; Huang Y; Zhang L; Zhang C
    Biochem Biophys Res Commun; 2016 Aug; 476(4):574-579. PubMed ID: 27261434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-specific transcription factor Osterix increases vitamin D receptor gene expression in osteoblasts.
    Zhang C; Tang W; Li Y; Yang F; Dowd DR; MacDonald PN
    PLoS One; 2011; 6(10):e26504. PubMed ID: 22028889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix.
    Zhang C; Cho K; Huang Y; Lyons JP; Zhou X; Sinha K; McCrea PD; de Crombrugghe B
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6936-41. PubMed ID: 18458345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of Vascular Endothelial Growth Factor (VEGF) by osteoblast-specific transcription factor Osterix (Osx) in osteoblasts.
    Tang W; Yang F; Li Y; de Crombrugghe B; Jiao H; Xiao G; Zhang C
    J Biol Chem; 2012 Jan; 287(3):1671-8. PubMed ID: 22110141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of Wnt pathway by HIF-1α and osteoblast-specific transcription factor osterix (Osx) in osteoblasts.
    Chen D; Li Y; Zhou Z; Xing Y; Zhong Y; Zou X; Tian W; Zhang C
    PLoS One; 2012; 7(12):e52948. PubMed ID: 23300831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblast-specific transcription factor Osterix (Osx) and HIF-1α cooperatively regulate gene expression of vascular endothelial growth factor (VEGF).
    Chen D; Tian W; Li Y; Tang W; Zhang C
    Biochem Biophys Res Commun; 2012 Jul; 424(1):176-81. PubMed ID: 22750006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osterix controls cementoblast differentiation through downregulation of Wnt-signaling via enhancing DKK1 expression.
    Cao Z; Liu R; Zhang H; Liao H; Zhang Y; Hinton RJ; Feng JQ
    Int J Biol Sci; 2015; 11(3):335-44. PubMed ID: 25678852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter.
    Hewitt J; Lu X; Gilbert L; Nanes MS
    Endocrinology; 2008 Jul; 149(7):3698-707. PubMed ID: 18372333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation.
    Lu X; Beck GR; Gilbert LC; Camalier CE; Bateman NW; Hood BL; Conrads TP; Kern MJ; You S; Chen H; Nanes MS
    J Bone Miner Res; 2011 Jan; 26(1):209-19. PubMed ID: 20683885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone.
    Barbuto R; Mitchell J
    J Mol Endocrinol; 2013; 51(1):99-108. PubMed ID: 23682129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osterix and NO66 histone demethylase control the chromatin of Osterix target genes during osteoblast differentiation.
    Sinha KM; Yasuda H; Zhou X; deCrombrugghe B
    J Bone Miner Res; 2014 Apr; 29(4):855-65. PubMed ID: 24115157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation.
    Xie J; Gu J
    J Cell Mol Med; 2015 Aug; 19(8):1814-24. PubMed ID: 25818514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways.
    Lu X; Gilbert L; He X; Rubin J; Nanes MS
    J Biol Chem; 2006 Mar; 281(10):6297-306. PubMed ID: 16410254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of osteoblast-specific transcription factor Osterix effect on bone formation.
    Zhang C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):659-65. PubMed ID: 23073571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase.
    Sinha KM; Yasuda H; Coombes MM; Dent SY; de Crombrugghe B
    EMBO J; 2010 Jan; 29(1):68-79. PubMed ID: 19927124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.